According to GuruFocus' list of 52-week highs, these guru stocks have reached their 52-week highs.
Exelon Corp. (EXCU, Financial) reached the 52-week high of $51.95
Exelon Corp. is a power retailer engaged in the utilities sector of the U.S. The company is involved in power generation and transmission activities. The Generation segment generates maximum revenue for the company. Since acquiring Pepco in 2016, Exelon serves more customers than any other U.S. utility, with 10 million power and gas customers at its six regulated utilities in Illinois, Pennsylvania, Maryland, New Jersey, Delaware and Washington, D.C. Exelon owns 11 nuclear plants and 33 gigawatts of generation capacity throughout North America, producing 20% of U.S. nuclear power and 5% of all U.S. electricity. The company is the largest power retailer in the U.S., serving about 200 terawatt-hours of load.
The price of Exelon Corp. shares have reached $51.95, which is 0.8% off the 52-week high of $52.36. Exelon Corp. has a market cap of $33.16 billion; its shares were traded around $51.95 with a P/E ratio of 9.50 and P/S ratio of 1.07. The trailing 12-month dividend yield of Exelon Corp. stock is 1.56%. The forward dividend yield of Exelon Corp. stock is 6.26%. Exelon Corp. had an annual average earnings growth of 6.40% over the past five years.
Exelon Corp. recently reported its financial results for the fourth quarter and full year 2017. Exelon's GAAP net income for the fourth quarter 2017 increased to $1.94 per share from 22 cents per share in the fourth quarter of 2016; adjusted (non-GAAP) operating earnings increased to 55 cents per share in the fourth quarter of 2017 from 44 cents per share in the fourth quarter of 2016.Â
Agrium Inc. (AGU, Financial) reached the 52-week high of $115.00
Agrium Inc. is a retail supplier of agricultural products and services in North and South America and producer and marketer of agricultural nutrients and industrial products. With more than 1,400 retail centers, Canada-based Agrium is the largest agricultural retailer in the U.S., selling fertilizers, crop chemicals and seed directly to farm customers. The company's wholesale business produces and markets the three main crop nutrients --nitrogen, potash, and phosphate -- with natural resources located mainly in Canada and the U.S. The bulk of Agrium's sales are generated in the U.S., Canada and Australia.
The price of Agrium Inc. shares has reached $115.00, which is -1.5% off the 52-week high of $113.25. Agrium Inc. has a market cap of $15.84 billion; its shares were traded around $115.00 with a P/E ratio of 39.72 and P/S ratio of 1.09. The trailing 12-month dividend yield of Agrium Inc. stocks is 3.04%. The forward dividend yield of Agrium Inc. stocks is 3.04%. Agrium Inc. had an annual average earnings growth of 16.10% over the past 10 years.
Nutrien Ltd. (Nutrien) announced recently fourth quarter 2017 results for Agrium Inc. Agrium fourth-quarter earnings from continuing operations, adjusted for items not included in guidance, were 78 cents per share. 2017 earnings for Agrium were supported by record retail Ebitda of $1.2 billion and margins of 10%.
Bioverativ Inc. (BIVV, Financial) reached the 52-week high of $104.98
Bioverativ Inc. is a global biotechnology company which focuses on the discovery, research, development and commercialization of innovative therapies for the treatment of hemophilia and other blood disorders. Its products include Eloctate and Alprolix. Bioverativ Inc. is a biotech focused on rare blood disorders and has two marketed hemophilia products: Eloctate (hemophilia A) and Alprolix (hemophilia B). Bioverativ spun off from Biogen in February 2017. Bioverativ's partner Swedish Orphan Biovitrum holds rights to these therapies and pipeline hemophilia therapies in many markets outside the U.S. Bioverativ is building a pipeline in rare blood-related disorders, such as TNT009 (part of the True North acquisition) in cold agglutinin disease and other hematology-focused drug candidates. Sanofi's pending acquisition of Bioverativ was announced in January 2018.
The price of Bioverativ Inc. shares has reached $104.98, which is 0.0% off the 52-week high of $105.01. Bioverativ Inc. has a market cap of $11.36 billion; its shares were traded around $104.98 with a P/E ratio of 32.01 and P/S ratio of 9.75.
Bioverativ Inc. recently reported financial results for the fourth quarter and full year of 2017. Highlights include:
- Fourth quarter 2017 revenues of $328.7 million, up 28.3% year-over-year.
- Fourth quarter 2017 revenues increased $37.1 million over third quarter 2017, up 12.7%.
- Fourth quarter 2017 GAAP net income of $141.3 million; non-GAAP net income of $103.3 million.
- Full-year 2017 GAAP tax rate of 21.3%; non-GAAP tax rate of 34.3%.
Discovery Inc. (DISCB, Financial) reached the 52-week high of $37.75
Discovery Communications Inc. is a media and entertainment company. It provides programming across multiple distribution platforms. The company also provides educational products and services to schools and operates digital media services. Discovery is one of the largest global media providers with over 2 billion cumulative subscribers in over 220 countries. Its three main networks (Discovery, TLC and Animal Planet) each reach over 89 million U.S. households and more than 270 million international subscribers. The firm operates eight other channels in the U.S., including Investigation Discovery and OWN: Oprah Winfrey Network. The international segment consists of national and pan-regional networks over 294 unique distribution feeds in more than 45 languages.
The price of Discovery Inc. shares has reached $37.75, which is 0.7% off the 52-week high of $38.00. Discovery Inc. has a market cap of $10.13 billion; its shares were traded around $37.75 with and P/S ratio of 1.76. Discovery Inc. had an annual average earnings growth of 18.40% over the past 10 years.
Discovery Communications Inc. recently reported financial results for the fourth quarter ended Dec. 31, 2017. Fourth quarter revenues of $1.86 billion increased 11% compared to the prior year. Fourth quarter DCI net income decreased to $(1.14) billion. Diluted earnings per share decreased to $(1.99) due to lower DCI net income. Adjusted earnings per share decreased 16%, while adjusted earnings per share excluding currency effects increased 1%.
Marathon Petroleum Corp. (MPC, Financial) reached the 52-week high of $73.68
Marathon Petroleum Corp. is engaged in the oil & gas sector. The company is engaged in refining, marketing, retail and transportation of petroleum products in the U.S. Marathon Petroleum is an independent refiner with seven refineries in the midcontinent and Gulf Coast of the U.S. with total throughput capacity of 1.7 million barrels per day. Its Speedway retail segment sells transportation fuels through 2,740 stores. The firm also owns and operates crude oil and refined product pipelines. In 2012, Marathon spun off some of these assets into a master limited partnership, MPLX.
The price of Marathon Petroleum Corp. shares has reached $73.68, which is 1.1% off the 52-week high of $74.48. Marathon Petroleum Corp. has a market cap of $34.95 billion; its shares were traded around $73.68 with a P/E ratio of 10.97 and P/S ratio of 0.50. The trailing 12-month dividend yield of Marathon Petroleum Corp. stocks is 2.18%. The forward dividend yield of Marathon Petroleum Corp. stocks is 2.58%. Marathon Petroleum Corp. had an annual average earnings growth of 5.30% over the past five years.
Marathon Petroleum Corp. recently reported 2017 fourth quarter earnings of $2.02 billion, or $4.09 per diluted share, compared with $227 million, or 43 cents per diluted share, in the fourth quarter of 2016. Earnings were $3.43 billion, or $6.70 per diluted share, for the full-year 2017, compared with $1.17 billion, or $2.21 per diluted share, for the full-year 2016.
Chairman and CEO Gary R. Heminger sold 55,178 shares of Marathon Petroleum stock on Feb. 26, 2018, at the price of $66.47 per share. The price of the stock has increased by 10.85% since.
Note: I do not own the stocks discussed.
